| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Xu,Zhang-Yao | Chairman | 0.00% | |
| Xu,Wen-Hong | Director | 0.00% | |
| Wu,Rui-Wen | Director | 17.76% | TTY BIOPHARM COMPANY LIMITED |
| Wu,Ming-Xian | Director | 15.50% | NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN |
| Lin,Yi-Hui | Director | 15.50% | NATIONAL DEVELOPMENT FUND MANAGEMENT COMMITTEE, EXECUTIVE YUAN |
| Hou,Ming-Feng | Director | 0.00% | |
| Qiu,Wen-Da | Independent Director | 0.00% | |
| Luo,Bao-Zhu | Independent Director | 0.02% | |
| Lin,Jian-Huang | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 187,382 | 2,523,304 | 767,669 |
| Operating cost | 12,384 | 47,740 | 48,697 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 174,998 | 2,475,564 | 718,972 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 174,998 | 2,475,564 | 718,972 |
| Operating expenses | 86,209 | 422,398 | 441,789 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 88,789 | 2,053,166 | 277,183 |
| Non-operating income and expenses | 39,092 | 109,829 | 60,791 |
| Net profit (loss) before tax | 127,881 | 2,162,995 | 337,974 |
| Income tax expense (benefits) | 25,578 | 411,965 | 63,324 |
| Net profit (loss) of ongoing business for the current period | 102,303 | 1,751,030 | 274,650 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 102,303 | 1,751,030 | 274,650 |
| Other comprehensive profit (loss), net | - | - | - |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 102,303 | 1,751,030 | 274,650 |
| Net profit (loss) attributable to owners of parent company | - | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 12 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 1,808,966 | - | - |
| Net cash inflows (outflows) from investing activities | 209,815 | - | - |
| Net cash inflow (outflow) from financing activities | -1,937 | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 2,016,844 | - | - |
| Beginning balance of cash and cash equivalents | 993,699 | - | - |
| Ending balance of cash and cash equivalents | 3,010,543 | - | - |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 5,933,548 | 5,827,444 | 3,923,020 |
| Non-current asset | 19,608 | 20,367 | 30,899 |
| Total asset | 5,953,156 | 5,847,811 | 3,953,919 |
| Current liability | 444,729 | 443,053 | 83,863 |
| Non-current liability | 6,148 | 4,960 | 7,143 |
| Total liability | 450,877 | 448,013 | 91,006 |
| share capital | 1,456,776 | 1,456,776 | 1,456,782 |
| Equity - secruity token | - | - | - |
| capital reserve | 1,615,939 | 1,615,939 | 1,616,011 |
| retained earning | 2,563,199 | 2,460,896 | 925,310 |
| Other equity | -225 | -403 | -1,780 |
| Treasury stock | -133,410 | -133,410 | -133,410 |
| Total equity attributable to owners of parent company | - | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 5,502,279 | 5,399,798 | 3,862,913 |
| Share capital awaiting retirement (unit: share) | 0 | 300 | 600 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 2,000,000 | 2,000,000 | 2,000,000 |
| Net asset value per share | 38 | 37 | 26 |
